We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Venn Life Sciences Holdings Plc | LSE:VENN | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.85 | 6.70 | 7.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMVENN
RNS Number : 3562I
Venn Life Sciences Holdings PLC
21 March 2018
21 March 2018
Venn Life Sciences Holdings Plc
("Venn" or the "Company")
Resignation of Director
Venn Life Sciences ("Venn") an Integrated Drug Development Partner offering a combination of drug development expertise and clinical trial design and management to pharmaceutical, biotechnology and medical device organisations announces that Jonathan Hartshorn is to step down from his position as Finance Director of the Company with immediate effect.
Tony Richardson said "Jonathan is moving on to pursue other opportunities. I would like to thank him for his contribution and wish him well in his future endeavours". The Company will in due course announce a permanent replacement but, in the meantime, the finance function will report directly to the Chief Executive Officer.
Enquiries:
Venn Life Sciences Holdings Plc Allan Wood, Non-Executive Chairman Tony Richardson, Chief Executive Officer Tel: +353 1 5499341 Cenkos (Nominated Advisor and Joint Tel: +44(0)20 3764 2341 Broker) Mark Connelly/Steve Cox (Corporate Finance) Davy (ESM Adviser and Joint Broker) Fergal Meegan / Matthew de Vere Tel: +353 1 679 6363 White (Corporate Finance) Hybridan LLP (Joint Broker) Tel: +44 (0)20 3764 2341 Claire Louise Noyce
About Venn Life Sciences: Venn Life Sciences is an Integrated Drug Development Partner offering a unique combination of drug development expertise and clinical trial design and management to pharmaceutical, biotechnology and medical device organisations. Venn have dedicated operations in France, Germany, the Netherlands, the UK, Ireland with partners across Europe and the US.
Further information in relation to Venn Life Sciences www.vennlifesciences.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOABRGDXCDDBGIG
(END) Dow Jones Newswires
March 21, 2018 03:01 ET (07:01 GMT)
1 Year Venn Life Sciences Chart |
1 Month Venn Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
